Histogen | 15-12G: Notice of termination of registration of a class of securities under Section 12(g) (and amendment thereto)
Histogen | DEFA14A: Others
Histogen | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Histogen | 8-K: Current report
Histogen | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Histogen | 8-K: Current report
Histogen | S-8 POS: S-8 POS
Histogen | S-8 POS: S-8 POS
Histogen | S-8 POS: S-8 POS
Histogen | S-8 POS: S-8 POS
Histogen | DEFA14A: Others
Histogen: Q3 2023 Earnings Report
Histogen | DEF 14A: Definitive information statements
Histogen | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)
Histogen | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Histogen | 8-K: Current report
Histogen | 8-K: Current report
Histogen | 8-K: Current report
Histogen | 8-K: Current report
Histogen | 10-Q: Q2 2023 Earnings Report
No Data